OptTEST builds on the multi-disciplinary and multi-stakeholder platform of HIV in Europe.
Project aims: Help reduce the number of undiagnosed people with HIV infection and newly diagnosed late presenters in the European regions, and to promote timely treatment and care. The project is developing and piloting tools for assessing and implementing HIV testing programmes that are context-sensitive, ie. taking into account the various factors that impact on programme success. It will focus on priority regions and groups throughout Europe.
Duration: 36 months – from June 2014
Main partners: CHIP, Rigshospitalet, University of Copenhagen, DK
Associated partners: AIDS Fonds Stop AIDS now! Soa AIDS, NL; European AIDS Treatment Group, Belgium; Public Health of England, UK; St. Stephens AIDS Trust, UK; MEDFASH, UK ; Institute Nationale de la Santé et de la recherche Médicale, France; Stitching Global Network of People living with HIV/AIDS -GNP+; Instituto de Salud Carlos III, Madrid, Spain; National Institute for Health Development, Tallinn, Estonia.
EATG participation: involved in the coordination, dissemination and evaluation of the project and deliverable on legal and regulatory barriers to testing and linkage to care. This includes barriers to low threshold services providing testing and supporting linkage to care.
Main funding source: co-funded by the EU Public Health programme.
OptTEST newsletter No.7, June 2016: https://copenhagen-hiv-programme-cphiv.clients.ubivox.com/newsletter/727339/87844013/7770251/